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We congratulate and are grateful to JPMA for pub-
lishing a whole issue dedicated to cerebral venous sinus
thrombosis. This is a unique collaborative effort of clini-
cians and researchers from Saudi Arabia, Qatar, India,
Turkey, USA, and Pakistan. This issue contains more than
twenty review articles related to various aspects of CVT in
addition to one original article and 4 case reports.
The impetus for this effort is clear.  Cerebral venous
sinus thrombosis appears to be a problem which is more
common in the Asian region than the West. Recently
Panagariya a et al from India reported that CVT accounts for
half of all young strokes and 40% of strokes in women.1,2
Thus, it is an important disease in the local context and needs
to be picked up with a high index of suspicion. The progno-
sis of this disease is excellent with early diagnosis and insti-
tution of therapy. In the recent years, markers of those
patients that will do poorly on presentation have become
available from large international trials. Mortality usually
ranges from 6-15% and transtentorial herniation is the major
cause of death. Approximately 80% of patients are function-
ally independent in the long term.3
Older age (>37 years in ISCVT), male sex, seizures
at admission, rapid evolution of thrombosis, the presence of
focal deficits and CNS infection and cancer as the underly-
ing cause also predict poor outcome.4 ISCVT found
involvement of cortical veins, deep cerebral veins and supe-
rior sagittal sinus, intracerebral haemorrhage on right side,
posterior fossa lesions and parenchymal lesions especially
ones >5 cm in their larger diameter to be poor prognostic
factors.4 The clinical setting affects outcome, infections,
cancer patients may do poorly, contrary to that, obstetric
CVT may have a good outcome. 
The etiology of CVST is diverse and profound, and
must be suspected in settings of inflammatory disease,
malignancy, oral contraceptive use, and even as a complica-
tion post lumbar puncture for other reasons.5,6 Up to 40%
cases remain to be idiopathic. We believe a large number of
these cases in future will turn out to be genetically predis-
posed. The article from Arsalan7 discusses this increasingly
recognized factor related to CVT. Almost 25% cases of
CVT are due to known inherited causes of venous thrombo-
sis.   
The presenting symptoms include headache, focal
seizures and pappilloedema. Importantly, headache can be
the sole presenting symptom in about 80% of patients, and
can vary from a non specific headache to an acute thunder-
clap headache.8 In addition , this must be suspected in
patients with isolated pseudotumor cerebri and an MRV
must be obtained.9 Ravishankar10 has discussed incidence
and pattern of headache in CVT and headache profile relat-
ed to CVT in this issue. 
The diagnostic armamentarium consists of CT brain
with and without contrast, MRI/ MRV and angiography .
The sensitivity and specificity of CT scan in the diagnosis
of CVT is 68% and 52%, respectively. It may be totally nor-
mal in up to 26% of patients with proven CVT.11 In the first
two weeks, thrombotic blood is usually hyperdense on an
unenhanced CT scan compared to the brain parenchyma;
therefore, acutely dense cord sign, dense jugular vein, dense
triangle or dense delta sign, dense dural sinuses, these signs
are usually present during the first two weeks only.After
two weeks, a thrombus will become isointense to brain
parenchyma and therefore will only be visible on a postcon-
trast CT scan. In addition parasaggital haemorrhage not
respecting arterial territories may be seen.12 The newer gen-
eration  CT scanners allow venography with a resolution
comparable to MRI in minutes . 
MRI allows delineation of pathology via non inva-
sive imaging and allows distinction via functional MRI
techniques like diffusion weighted imaging of patients with
cytotoxic vs vasogenic oedema. Since the pathology often
incorporates vasogenic oedema, it explains why the progno-
sis of venous infarction is often better than its arterial coun-
terpart.13,14
Angiography with a venous phase study is often not
used as a first line, but may be useful in demonstrating ret-
rograde flow seen on real-time suggesting underlying
venous thrombosis through abnormal collateral channels. It
should also be considered when the administration of local
fibrinolytic therapy or mechanical clot maceration is
planned.15
The standard of care is dose adjusted unfractionated
heparin, this has been shown to be safe inspite of CNS
haemorrhage.16 Patients who deteriorate and progress
despite anticoagulation may be candidates for intraclot
interventional therapy and the recent experience, including
a report here about pediatric CVT is encouraging in terms of
eventual outcome.17,18
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Those suffering from malignant cerebral hypertension
may respond to decompressive hemicraniectomy despite
fixed pupils in 3 reported cases.19 The decompressive proce-
dure usually consists of removal of a large bone flap along
with a dural patch either from artificial dura or autologous tis-
sue such as pericranium, temporalis fascia, or fascia lata. In
addition to the removal of bone flap, the neurosurgeon may
also consider resecting infracted brain tissue and/or evacua-
tion of haematoma.  The recommended size of dural patch is
15 to 20 cm in length and 2.5 to 3 cm in width.  The bone flap
may be replaced after 4 to 12 weeks depending upon com-
plete resolution of swelling and medical fitness of the patient.
If thrombosis is in the cerebellar veins with consequent oede-
matous cerebellar infarcts suboccipital craniotomy is the
appropriate procedure.  These extreme measures must be
considered especially if widespread irreversible infarction
has not set in. 
The long term prognosis of survivors is good, both in
obstetric and other CVT, with negligible rates of recurrence.
Outpatient management consists of using warfarin for upto
6 months (following the venous thrombosis paradigm) and
monitoring for recanalization via MRV(magnetic  resonance
venogram). Data show that CVST patients display a high
spontaneous and intrinsic thrombolytic potential, with
recanalization rates of 60% during the first 20 days.20
Thereafter, recanalization rates increase insignificantly.
Recanalization may not be the only effective marker of
prognosis, the presence of venous collaterals may also be
important. 
There are also many unanswered questions, what is
the distribution of prothrombotic disease in Asia?  Would
patients benefit from early thrombolysis if they are identi-
fied as having poor prognostic factors?  Would additional
platelet blockade help? The idea of this supplement is to
raise as many questions as there are answers. The time is
ripe for a pragmatic Asian cerebral venous thrombosis trial
and a collaborative database. 
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